Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$1.09B |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$497M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$462M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.14B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$834M |
| 3 |
DuPont de Nemours
DD
|
+$438M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$367M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.52% |
| 2 | Financials | 7.65% |
| 3 | Consumer Discretionary | 5.72% |
| 4 | Communication Services | 5.59% |
| 5 | Healthcare | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMBM
3226
DELISTED
Cambium Networks
CMBM
| $432K | ﹤0.01% |
9,232
+7,431
| +413% | +$295K |
|
3227
Lindblad Expeditions
LIND
$1.94B
| $432K | ﹤0.01% |
22,845
+14,529
| +175% | +$264K |
|
3228
Sunoco
SUN
$14.4B
| $432K | ﹤0.01% |
13,554
+55
| +0.4% | +$1.72K |
|
3229
VEON
VEON
$3.62B
| $432K | ﹤0.01% |
9,771
+5,451
| +126% | +$239K |
|
3230
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.55B
| $432K | ﹤0.01% |
10,942
-4,460
| -29% | -$168K |
|
3231
Mercantile Bank Corp
MBWM
$1.04B
| $431K | ﹤0.01% |
13,266
+2,257
| +21% | +$68K |
|
|
ASLN
3232
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| $431K | ﹤0.01% |
+3,215
| New | +$407K |
|
3233
CALL
Shake Shack
SHAK
$2.53B
| $429K | ﹤0.01% |
3,800
-5,700
| -60% | -$652K |
|
3234
Miller Industries
MLR
$573M
| $428K | ﹤0.01% |
9,277
+5,695
| +159% | +$239K |
|
3235
Rayonier
RYN
$6.55B
| $428K | ﹤0.01% |
14,628
-6,948
| -32% | -$205K |
|
3236
Napco Security Technologies
NSSC
$1.32B
| $427K | ﹤0.01% |
24,540
+17,026
| +227% | +$263K |
|
|
CO
3237
DELISTED
Global Cord Blood Corporation
CO
| $426K | ﹤0.01% |
+94,132
| New | +$408K |
|
3238
Lands' End
LE
$370M
| $425K | ﹤0.01% |
17,137
+9,144
| +114% | +$268K |
|
|
ZYXI
3239
DELISTED
Zynex
ZYXI
| $424K | ﹤0.01% |
30,572
-5,895
| -16% | -$90K |
|
3240
Tidewater
TDW
$3.73B
| $423K | ﹤0.01% |
33,784
+20,739
| +159% | +$251K |
|
|
SPNE
3241
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $423K | ﹤0.01% |
24,320
+22,966
| +1,696% | +$412K |
|
3242
Acadia Healthcare
ACHC
$2.76B
| $422K | ﹤0.01% |
7,371
-31,086
| -81% | -$1.68M |
|
3243
PagerDuty
PD
$816M
| $419K | ﹤0.01% |
10,408
-63,885
| -86% | -$2.92M |
|
|
ISEE
3244
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $419K | ﹤0.01% |
67,887
+1,331
| +2% | +$8.08K |
|
|
LITS
3245
Lite Strategy Inc
LITS
$32.8M
| $418K | ﹤0.01% |
6,094
+2,814
| +86% | +$197K |
|
3246
Vera Bradley
VRA
$97M
| $418K | ﹤0.01% |
41,393
-1,350
| -3% | -$12.7K |
|
3247
Accuray
ARAY
$32M
| $417K | ﹤0.01% |
84,368
+22,306
| +36% | +$115K |
|
3248
BlueLinx
BXC
$422M
| $416K | ﹤0.01% |
+10,606
| New | +$412K |
|
|
CODX
3249
Co-Diagnostics
CODX
$5.31M
| $416K | ﹤0.01% |
1,454
-3,162
| -69% | -$1.26M |
|
3250
Ardelyx
ARDX
$1.22B
| $415K | ﹤0.01% |
62,731
+35,886
| +134% | +$246K |
|
Similar funds
Barclays's Q1 2021 Portfolio in Review
As of Q1 2021, Barclays held 5,437 positions worth $186B, down 1.6% from $189B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays withdrew a net $12.6B in Q1 2021, closing 755 positions and reducing 1,271 holdings. Its most notable exit was Stellantis, an estimated $264M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.6% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in Ferguson worth $253M.
- Barclays's largest Q1 2021 buy was Ferguson: 2,109,370 shares worth $253M.
- Barclays added most to Apple in Q1 2021, an estimated $1.24B increase.
- Barclays's biggest Q1 2021 reduction was iShares US Real Estate ETF, cutting an estimated $1.14B.
- Barclays fully exited Stellantis in Q1 2021, selling an estimated $264M.
- Barclays's ten largest holdings make up 37% of its $186B portfolio in Q1 2021.
- Barclays opened 555 new positions and closed 755 in Q1 2021.
- Barclays's portfolio value fell 1.6% quarter-over-quarter to $186B.
Based on Barclays's 13F filing for Q1 2021, filed 13 May 2021.